Improve sleep quality through exercise
- Trial ID
- NCT05644327
- Official Title
- The Effects of Different Exercise Modalities on Sleep Quality and Architecture in People With Parkinson's Disease
- Goal
- Improve sleep quality through exercise
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- McGill University
- Study Type
- INTERVENTIONAL
- Enrollment
- 150 participants
- Conditions
- Parkinson Disease
- Interventions
- Cardiovascular training (CT), Resistance training (RT), Multimodal training (MT)
Plain-Language Summary
They want to find which kind of exercise best improves sleep quality and the makeup of sleep in people with Parkinson's, for example increasing deep restorative sleep and cutting down nighttime awakenings. Participants are assigned to cardiovascular training, resistance training, or a combined program, with cardio raising heart rate and aerobic fitness to strengthen circadian cues and slow wave sleep, resistance work building muscle to reduce nighttime stiffness and sleep disruption, and the combined approach doing both. Exercise here is a nonpharmacologic complement to medications like levodopa; it does not change how levodopa works but may lessen nocturnal motor symptoms and improve sleep without adding drug side effects. The trial seeks adults 40 and over with mild to moderate idiopathic Parkinson's (Hoehn and Yahr 0.5,3.5), on stable meds and reporting poor sleep (PDSS-2 >15), while excluding people with dementia, severe untreated sleep apnea, major cognitive or depressive impairment, serious exercise contraindications, or who are already highly active.
Locations
- Jewish Rehabilitation Hospital, Laval, Quebec, Canada
- Human Brain Control of Locomotion Laboratory, Montreal, Quebec, Canada
- Cummings Centre, Montreal, Quebec, Canada
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Cardiovascular training (CT). They want to find which kind of exercise best improves sleep quality and the makeup of sleep in people with Parkinson's, for example increasing deep restorative sleep and cutting down nighttime awakenings. Participants are assigned to cardiovascular training, resistance training, or a combined program, with cardio raising heart rate and aerobic fitness to strengthen circadian cues and slow wave sleep, resistance work building muscle to reduce nighttime stiffness and sleep disruption, and the combined approach doing both. Exercise here is a nonpharmacologic complement to medications like levodopa; it does not change how levodopa works but may lessen nocturnal motor symptoms and improve sleep without adding drug side effects. The trial seeks adults 40 and over with mild to moderate idiopathic Parkinson's (Hoehn and Yahr 0.5,3.5), on stable meds and reporting poor sleep (PDSS-2 >15), while excluding people with dementia, severe untreated sleep apnea, major cognitive or depressive impairment, serious exercise contraindications, or who are already highly active.
- Who can participate?
- Participants must be at least 40 Years.
- Where is this trial located?
- This trial is recruiting at 3 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 years and 4 months.